0 Synthetic polio vaccine developed using plants
Researchers have pioneered a synthetic polio vaccine using a plant-based production technique. They suggest their findings could be a major step towards the global eradication of this disease.
Browsing: Clinical > Vaccines
0 MMR vaccination: Pro-vaccination strategies fail to debunk popular misconceptions
A study has suggested that the current strategies aimed at changing perceptions towards measles, mumps and rubella vaccinations only serve to reinforce these false beliefs.
0 Working at the interface between disciplines: Why not share our music playlists and dance together? – an interview with Natasha Crowcroft
In this interview, we discuss public health and music playlists with Natasha Crowcroft, Chief of Applied Immunization Research and Evaluation at Public Health Ontario and Professor in Laboratory Medicine and Pathobiology and the Dalla Lana School of Public Health at the University of Toronto.
0 Chikungunya vaccine to enter Phase II trials in endemic areas
A chikungunya vaccine, developed by Themis Bioscience GmbH will be assessed for safety and efficacy in Phase II trials in Puerto Rico from August 2017.
0 IAS 2017: APPROACH trial reports promise for investigational HIV vaccine
Results from the early-stage APPROACH trial have demonstrated an investigational HIV vaccine regimen, based on mosaic vaccines, has been well-tolerated and immunogenic in healthy participants.
0 Measles – small reduction in vaccination would have a large impact
A new study has suggested that a small drop in the number of children vaccinated against measles in the US would lead to a disproportionately large number of cases.
0 Zika – an update on the vaccine pipeline
Is a Zika vaccine imminent? Editor, Martha Powell, provides an overview of the current Zika vaccine candidates in human clinical trials and how these vaccines are being assessed.
0 Meningitis vaccine could protect against gonorrhoea
Following a warning from the WHO about concerning antibiotic resistance in gonorrhoea, a vaccine originally developed for meningitis has shown promise for protecting against this disease.
0 21st century challenges in an influenza pandemic
The threat of future influenza pandemics demands that public health, governments and health care providers grapple with complex communication challenges. Read more on attitudes towards influenza in our latest opinion piece.
0 Phase I trial results promising for flu vaccine microneedle patches
A Phase I clinical trial has demonstrated that microneedle patches for flu vaccinations are safe, well-tolerated, immunogenic and also preferred by participants over intramuscular injection.